Ontology type: schema:ScholarlyArticle Open Access: True
2021-12-23
AUTHORSChris Skedgel, Eleanor Ralphs, Elaine Finn, Marie Markert, Carl Samuelsen, Jennifer A. Whitty
ABSTRACTObjectivesAssistive reproductive therapies can help those who have difficulty conceiving but different forms of assistive reproductive therapies are associated with different treatment characteristics. We undertook a large, multinational discrete choice experiment to understand patient preferences for assistive reproductive therapies.MethodsWe administered an online discrete choice experiment with persons who had experience with subfertility or assistive reproductive therapies in the USA, UK, the Nordic region (Denmark, Norway, Sweden, Finland), Spain, and China. Attributes encouraged trade-offs between effectiveness, risk of adverse effects, treatment (dis)comfort, (in)convenience, cost per cycle and shared decision making. We used multinomial logit and mixed-logit models to estimate preferences and attribute importance by country/region, and estimated willingness to pay for changes in attribute levels.ResultsA total of 7565 respondents participated. Mixed logit had a better fit than multinomial logit across all samples. Preferences moved in expected directions across all samples, but the relative importance of attributes differed between countries. Willingness to pay was greatest for improvements in effectiveness and a greater degree of shared decision making, and we observe a substantial ‘option value’ independent of treatment characteristics. Unexpectedly, preferences over cost were insignificant in the Chinese sample, limiting the use of willingness to pay in this sample.ConclusionsRespondents balanced concerns for effectiveness with other considerations, including the cost and (dis)comfort of treatment, and the degree of shared decision making, but there is also substantial option value independent of treatment characteristics, demonstrating value of assistive reproductive therapies to individuals with experience of subfertility. We hypothesise that price insensitivity in the Chinese sample may reflect a degree of social desirability bias. More... »
PAGES1-14
http://scigraph.springernature.com/pub.10.1007/s40271-021-00563-7
DOIhttp://dx.doi.org/10.1007/s40271-021-00563-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1144121310
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/34940935
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, SW1E 6QT, London, UK",
"id": "http://www.grid.ac/institutes/grid.482825.1",
"name": [
"Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, SW1E 6QT, London, UK"
],
"type": "Organization"
},
"familyName": "Skedgel",
"givenName": "Chris",
"id": "sg:person.01215573243.83",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215573243.83"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "IQVIA, London, UK",
"id": "http://www.grid.ac/institutes/grid.482783.2",
"name": [
"IQVIA, London, UK"
],
"type": "Organization"
},
"familyName": "Ralphs",
"givenName": "Eleanor",
"id": "sg:person.011655170151.67",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011655170151.67"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "IQVIA, London, UK",
"id": "http://www.grid.ac/institutes/grid.482783.2",
"name": [
"IQVIA, London, UK"
],
"type": "Organization"
},
"familyName": "Finn",
"givenName": "Elaine",
"id": "sg:person.015320611536.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015320611536.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ferring Pharmaceuticals, Copenhagen, Denmark",
"id": "http://www.grid.ac/institutes/grid.417856.9",
"name": [
"Ferring Pharmaceuticals, Copenhagen, Denmark"
],
"type": "Organization"
},
"familyName": "Markert",
"givenName": "Marie",
"id": "sg:person.015144676723.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015144676723.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ferring Pharmaceuticals, Copenhagen, Denmark",
"id": "http://www.grid.ac/institutes/grid.417856.9",
"name": [
"Ferring Pharmaceuticals, Copenhagen, Denmark"
],
"type": "Organization"
},
"familyName": "Samuelsen",
"givenName": "Carl",
"id": "sg:person.011427527523.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011427527523.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Health Economics Group, University of East Anglia, Norwich, UK",
"id": "http://www.grid.ac/institutes/grid.8273.e",
"name": [
"Health Economics Group, University of East Anglia, Norwich, UK"
],
"type": "Organization"
},
"familyName": "Whitty",
"givenName": "Jennifer A.",
"id": "sg:person.01151123751.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151123751.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s40273-018-0734-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1107989556",
"https://doi.org/10.1007/s40273-018-0734-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40738-016-0019-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033018320",
"https://doi.org/10.1186/s40738-016-0019-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40271-019-00360-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1112971396",
"https://doi.org/10.1007/s40271-019-00360-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40273-014-0170-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014604000",
"https://doi.org/10.1007/s40273-014-0170-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrurol.2016.261",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040096353",
"https://doi.org/10.1038/nrurol.2016.261"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-12-23",
"datePublishedReg": "2021-12-23",
"description": "ObjectivesAssistive reproductive therapies can help those who have difficulty conceiving but different forms of assistive reproductive therapies are associated with different treatment characteristics. We undertook a large, multinational discrete choice experiment to understand patient preferences for assistive reproductive therapies.MethodsWe administered an online discrete choice experiment with persons who had experience with subfertility or assistive reproductive therapies in the USA, UK, the Nordic region (Denmark, Norway, Sweden, Finland), Spain, and China. Attributes encouraged trade-offs between effectiveness, risk of adverse effects, treatment (dis)comfort, (in)convenience, cost per cycle and shared decision making. We used multinomial logit and mixed-logit models to estimate preferences and attribute importance by country/region, and estimated willingness to pay for changes in attribute levels.ResultsA total of 7565 respondents participated. Mixed logit had a better fit than multinomial logit across all samples. Preferences moved in expected directions across all samples, but the relative importance of attributes differed between countries. Willingness to pay was greatest for improvements in effectiveness and a greater degree of shared decision making, and we observe a substantial \u2018option value\u2019 independent of treatment characteristics. Unexpectedly, preferences over cost were insignificant in the Chinese sample, limiting the use of willingness to pay in this sample.ConclusionsRespondents balanced concerns for effectiveness with other considerations, including the cost and (dis)comfort of treatment, and the degree of shared decision making, but there is also substantial option value independent of treatment characteristics, demonstrating value of assistive reproductive therapies to individuals with experience of subfertility. We hypothesise that price insensitivity in the Chinese sample may reflect a degree of social desirability bias.",
"genre": "article",
"id": "sg:pub.10.1007/s40271-021-00563-7",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1038760",
"issn": [
"1178-1653",
"1178-1661"
],
"name": "The Patient - Patient-Centered Outcomes Research",
"publisher": "Springer Nature",
"type": "Periodical"
}
],
"keywords": [
"discrete choice experiment",
"choice experiment",
"multinomial logit",
"option value",
"online discrete choice experiment",
"use of willingness",
"mixed logit model",
"different treatment characteristics",
"mixed logit",
"price insensitivity",
"countries/regions",
"attribute levels",
"logit",
"willingness",
"decision making",
"Nordic region",
"preferences",
"social desirability bias",
"relative importance",
"cost",
"desirability bias",
"patient preferences",
"making",
"countries",
"attributes",
"decisions",
"China",
"different forms",
"UK",
"Spain",
"different aspects",
"importance",
"greater degree",
"USA",
"values",
"bias",
"respondents",
"model",
"degree",
"effectiveness",
"risk",
"characteristics",
"concern",
"experience",
"consideration",
"Chinese sample",
"people",
"treatment characteristics",
"individuals",
"changes",
"ConclusionsRespondents",
"aspects",
"region",
"adverse effects",
"levels",
"effect",
"cycle",
"samples",
"results",
"direction",
"difficulties",
"persons",
"form",
"improvement",
"use",
"experiments",
"insensitivity",
"MethodsWe",
"ResultsA total",
"total",
"treatment",
"therapy",
"subfertility",
"reproductive therapy"
],
"name": "How Do People with Experience of Infertility Value Different Aspects of Assistive Reproductive Therapy? Results from a Multi-Country Discrete Choice Experiment",
"pagination": "1-14",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1144121310"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s40271-021-00563-7"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"34940935"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s40271-021-00563-7",
"https://app.dimensions.ai/details/publication/pub.1144121310"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:37",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_879.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s40271-021-00563-7"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40271-021-00563-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40271-021-00563-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40271-021-00563-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40271-021-00563-7'
This table displays all metadata directly associated to this object as RDF triples.
190 TRIPLES
22 PREDICATES
102 URIs
90 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s40271-021-00563-7 | schema:about | anzsrc-for:11 |
2 | ″ | schema:author | Nbeec770713554ebc86f0fd524b8d764c |
3 | ″ | schema:citation | sg:pub.10.1007/s40271-019-00360-3 |
4 | ″ | ″ | sg:pub.10.1007/s40273-014-0170-x |
5 | ″ | ″ | sg:pub.10.1007/s40273-018-0734-2 |
6 | ″ | ″ | sg:pub.10.1038/nrurol.2016.261 |
7 | ″ | ″ | sg:pub.10.1186/s40738-016-0019-4 |
8 | ″ | schema:datePublished | 2021-12-23 |
9 | ″ | schema:datePublishedReg | 2021-12-23 |
10 | ″ | schema:description | ObjectivesAssistive reproductive therapies can help those who have difficulty conceiving but different forms of assistive reproductive therapies are associated with different treatment characteristics. We undertook a large, multinational discrete choice experiment to understand patient preferences for assistive reproductive therapies.MethodsWe administered an online discrete choice experiment with persons who had experience with subfertility or assistive reproductive therapies in the USA, UK, the Nordic region (Denmark, Norway, Sweden, Finland), Spain, and China. Attributes encouraged trade-offs between effectiveness, risk of adverse effects, treatment (dis)comfort, (in)convenience, cost per cycle and shared decision making. We used multinomial logit and mixed-logit models to estimate preferences and attribute importance by country/region, and estimated willingness to pay for changes in attribute levels.ResultsA total of 7565 respondents participated. Mixed logit had a better fit than multinomial logit across all samples. Preferences moved in expected directions across all samples, but the relative importance of attributes differed between countries. Willingness to pay was greatest for improvements in effectiveness and a greater degree of shared decision making, and we observe a substantial ‘option value’ independent of treatment characteristics. Unexpectedly, preferences over cost were insignificant in the Chinese sample, limiting the use of willingness to pay in this sample.ConclusionsRespondents balanced concerns for effectiveness with other considerations, including the cost and (dis)comfort of treatment, and the degree of shared decision making, but there is also substantial option value independent of treatment characteristics, demonstrating value of assistive reproductive therapies to individuals with experience of subfertility. We hypothesise that price insensitivity in the Chinese sample may reflect a degree of social desirability bias. |
11 | ″ | schema:genre | article |
12 | ″ | schema:inLanguage | en |
13 | ″ | schema:isAccessibleForFree | true |
14 | ″ | schema:isPartOf | sg:journal.1038760 |
15 | ″ | schema:keywords | China |
16 | ″ | ″ | Chinese sample |
17 | ″ | ″ | ConclusionsRespondents |
18 | ″ | ″ | MethodsWe |
19 | ″ | ″ | Nordic region |
20 | ″ | ″ | ResultsA total |
21 | ″ | ″ | Spain |
22 | ″ | ″ | UK |
23 | ″ | ″ | USA |
24 | ″ | ″ | adverse effects |
25 | ″ | ″ | aspects |
26 | ″ | ″ | attribute levels |
27 | ″ | ″ | attributes |
28 | ″ | ″ | bias |
29 | ″ | ″ | changes |
30 | ″ | ″ | characteristics |
31 | ″ | ″ | choice experiment |
32 | ″ | ″ | concern |
33 | ″ | ″ | consideration |
34 | ″ | ″ | cost |
35 | ″ | ″ | countries |
36 | ″ | ″ | countries/regions |
37 | ″ | ″ | cycle |
38 | ″ | ″ | decision making |
39 | ″ | ″ | decisions |
40 | ″ | ″ | degree |
41 | ″ | ″ | desirability bias |
42 | ″ | ″ | different aspects |
43 | ″ | ″ | different forms |
44 | ″ | ″ | different treatment characteristics |
45 | ″ | ″ | difficulties |
46 | ″ | ″ | direction |
47 | ″ | ″ | discrete choice experiment |
48 | ″ | ″ | effect |
49 | ″ | ″ | effectiveness |
50 | ″ | ″ | experience |
51 | ″ | ″ | experiments |
52 | ″ | ″ | form |
53 | ″ | ″ | greater degree |
54 | ″ | ″ | importance |
55 | ″ | ″ | improvement |
56 | ″ | ″ | individuals |
57 | ″ | ″ | insensitivity |
58 | ″ | ″ | levels |
59 | ″ | ″ | logit |
60 | ″ | ″ | making |
61 | ″ | ″ | mixed logit |
62 | ″ | ″ | mixed logit model |
63 | ″ | ″ | model |
64 | ″ | ″ | multinomial logit |
65 | ″ | ″ | online discrete choice experiment |
66 | ″ | ″ | option value |
67 | ″ | ″ | patient preferences |
68 | ″ | ″ | people |
69 | ″ | ″ | persons |
70 | ″ | ″ | preferences |
71 | ″ | ″ | price insensitivity |
72 | ″ | ″ | region |
73 | ″ | ″ | relative importance |
74 | ″ | ″ | reproductive therapy |
75 | ″ | ″ | respondents |
76 | ″ | ″ | results |
77 | ″ | ″ | risk |
78 | ″ | ″ | samples |
79 | ″ | ″ | social desirability bias |
80 | ″ | ″ | subfertility |
81 | ″ | ″ | therapy |
82 | ″ | ″ | total |
83 | ″ | ″ | treatment |
84 | ″ | ″ | treatment characteristics |
85 | ″ | ″ | use |
86 | ″ | ″ | use of willingness |
87 | ″ | ″ | values |
88 | ″ | ″ | willingness |
89 | ″ | schema:name | How Do People with Experience of Infertility Value Different Aspects of Assistive Reproductive Therapy? Results from a Multi-Country Discrete Choice Experiment |
90 | ″ | schema:pagination | 1-14 |
91 | ″ | schema:productId | N05d3a77081074dc4aba163b383ca0fcf |
92 | ″ | ″ | N28ebe23637684583b0c158dc4db9edab |
93 | ″ | ″ | N3d342224293c43cea8aab4d6009c46af |
94 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1144121310 |
95 | ″ | ″ | https://doi.org/10.1007/s40271-021-00563-7 |
96 | ″ | schema:sdDatePublished | 2022-05-20T07:37 |
97 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
98 | ″ | schema:sdPublisher | N65f18c7bfa2d4f90b7738e7faa1da4a0 |
99 | ″ | schema:url | https://doi.org/10.1007/s40271-021-00563-7 |
100 | ″ | sgo:license | sg:explorer/license/ |
101 | ″ | sgo:sdDataset | articles |
102 | ″ | rdf:type | schema:ScholarlyArticle |
103 | N0181900b6ee443ddb2a5fce4fb942904 | rdf:first | sg:person.015144676723.14 |
104 | ″ | rdf:rest | N2536c0b7f2eb424487affc88978b7f3a |
105 | N05d3a77081074dc4aba163b383ca0fcf | schema:name | doi |
106 | ″ | schema:value | 10.1007/s40271-021-00563-7 |
107 | ″ | rdf:type | schema:PropertyValue |
108 | N2536c0b7f2eb424487affc88978b7f3a | rdf:first | sg:person.011427527523.31 |
109 | ″ | rdf:rest | Nd040b802a78d49b2bd3cbb87d52620d0 |
110 | N28ebe23637684583b0c158dc4db9edab | schema:name | pubmed_id |
111 | ″ | schema:value | 34940935 |
112 | ″ | rdf:type | schema:PropertyValue |
113 | N379fd31bab8040f0ad9b8bc333ff63b8 | rdf:first | sg:person.015320611536.23 |
114 | ″ | rdf:rest | N0181900b6ee443ddb2a5fce4fb942904 |
115 | N3d342224293c43cea8aab4d6009c46af | schema:name | dimensions_id |
116 | ″ | schema:value | pub.1144121310 |
117 | ″ | rdf:type | schema:PropertyValue |
118 | N578e70f903ac45ed83159071c1a85061 | rdf:first | sg:person.011655170151.67 |
119 | ″ | rdf:rest | N379fd31bab8040f0ad9b8bc333ff63b8 |
120 | N65f18c7bfa2d4f90b7738e7faa1da4a0 | schema:name | Springer Nature - SN SciGraph project |
121 | ″ | rdf:type | schema:Organization |
122 | Nbeec770713554ebc86f0fd524b8d764c | rdf:first | sg:person.01215573243.83 |
123 | ″ | rdf:rest | N578e70f903ac45ed83159071c1a85061 |
124 | Nd040b802a78d49b2bd3cbb87d52620d0 | rdf:first | sg:person.01151123751.90 |
125 | ″ | rdf:rest | rdf:nil |
126 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
127 | ″ | schema:name | Medical and Health Sciences |
128 | ″ | rdf:type | schema:DefinedTerm |
129 | sg:journal.1038760 | schema:issn | 1178-1653 |
130 | ″ | ″ | 1178-1661 |
131 | ″ | schema:name | The Patient - Patient-Centered Outcomes Research |
132 | ″ | schema:publisher | Springer Nature |
133 | ″ | rdf:type | schema:Periodical |
134 | sg:person.011427527523.31 | schema:affiliation | grid-institutes:grid.417856.9 |
135 | ″ | schema:familyName | Samuelsen |
136 | ″ | schema:givenName | Carl |
137 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011427527523.31 |
138 | ″ | rdf:type | schema:Person |
139 | sg:person.01151123751.90 | schema:affiliation | grid-institutes:grid.8273.e |
140 | ″ | schema:familyName | Whitty |
141 | ″ | schema:givenName | Jennifer A. |
142 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151123751.90 |
143 | ″ | rdf:type | schema:Person |
144 | sg:person.011655170151.67 | schema:affiliation | grid-institutes:grid.482783.2 |
145 | ″ | schema:familyName | Ralphs |
146 | ″ | schema:givenName | Eleanor |
147 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011655170151.67 |
148 | ″ | rdf:type | schema:Person |
149 | sg:person.01215573243.83 | schema:affiliation | grid-institutes:grid.482825.1 |
150 | ″ | schema:familyName | Skedgel |
151 | ″ | schema:givenName | Chris |
152 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215573243.83 |
153 | ″ | rdf:type | schema:Person |
154 | sg:person.015144676723.14 | schema:affiliation | grid-institutes:grid.417856.9 |
155 | ″ | schema:familyName | Markert |
156 | ″ | schema:givenName | Marie |
157 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015144676723.14 |
158 | ″ | rdf:type | schema:Person |
159 | sg:person.015320611536.23 | schema:affiliation | grid-institutes:grid.482783.2 |
160 | ″ | schema:familyName | Finn |
161 | ″ | schema:givenName | Elaine |
162 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015320611536.23 |
163 | ″ | rdf:type | schema:Person |
164 | sg:pub.10.1007/s40271-019-00360-3 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1112971396 |
165 | ″ | ″ | https://doi.org/10.1007/s40271-019-00360-3 |
166 | ″ | rdf:type | schema:CreativeWork |
167 | sg:pub.10.1007/s40273-014-0170-x | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1014604000 |
168 | ″ | ″ | https://doi.org/10.1007/s40273-014-0170-x |
169 | ″ | rdf:type | schema:CreativeWork |
170 | sg:pub.10.1007/s40273-018-0734-2 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1107989556 |
171 | ″ | ″ | https://doi.org/10.1007/s40273-018-0734-2 |
172 | ″ | rdf:type | schema:CreativeWork |
173 | sg:pub.10.1038/nrurol.2016.261 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1040096353 |
174 | ″ | ″ | https://doi.org/10.1038/nrurol.2016.261 |
175 | ″ | rdf:type | schema:CreativeWork |
176 | sg:pub.10.1186/s40738-016-0019-4 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1033018320 |
177 | ″ | ″ | https://doi.org/10.1186/s40738-016-0019-4 |
178 | ″ | rdf:type | schema:CreativeWork |
179 | grid-institutes:grid.417856.9 | schema:alternateName | Ferring Pharmaceuticals, Copenhagen, Denmark |
180 | ″ | schema:name | Ferring Pharmaceuticals, Copenhagen, Denmark |
181 | ″ | rdf:type | schema:Organization |
182 | grid-institutes:grid.482783.2 | schema:alternateName | IQVIA, London, UK |
183 | ″ | schema:name | IQVIA, London, UK |
184 | ″ | rdf:type | schema:Organization |
185 | grid-institutes:grid.482825.1 | schema:alternateName | Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, SW1E 6QT, London, UK |
186 | ″ | schema:name | Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, SW1E 6QT, London, UK |
187 | ″ | rdf:type | schema:Organization |
188 | grid-institutes:grid.8273.e | schema:alternateName | Health Economics Group, University of East Anglia, Norwich, UK |
189 | ″ | schema:name | Health Economics Group, University of East Anglia, Norwich, UK |
190 | ″ | rdf:type | schema:Organization |